Anlotinib combined with sintilimab as first-line treatment in patients with advanced non-clear cell renal cell carcinoma: Preliminary results from an exploratory prospective clinical study.

被引：0
|
作者：
Dong, Pei [1 ]
Wei, Wensu [1 ]
Jiang, Lijuan [1 ]
Zhang, Zhiling [1 ]
Guo, Shengjie [1 ]
Han, Hui [1 ]
Cai, Xiuyu [1 ]
Zhou, Fangjian [1 ]
机构：
[1] Sun Yat Sen Univ, Dept Urol, Canc Ctr, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16546
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Real-world evidence on first-line treatment for metastatic renal cell carcinoma with non-clear cell and sarcomatoid histologies: are sunitinib and pazopanib interchangeable?
    Bonadio, Renata Colombo
    Velho, Pedro Isaacsson
    Marta, Guilherme Nader
    Narda, Mirella
    La Souza, Manoel Carlos
    Muniz, David Q. B.
    Bezerra, Regis O. F.
    Bispo, Raisa K. A.
    Faraj, Sheila F.
    Bastos, Diogo A.
    Dzik, Carlos
    ECANCERMEDICALSCIENCE, 2019, 13
  • [32] Safety and Efficacy of Nivolumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma: Results From the Phase IIIb/IV CheckMate 374 Study
    Vogelzang, Nicholas J.
    Olsen, Mark R.
    McFarlane, Joshua J.
    Arrowsmith, Edward
    Bauer, Todd M.
    Jain, Rohit K.
    Somer, Bradley
    Lam, Elaine T.
    Kochenderfer, Mark D.
    Molina, Ana
    Doshi, Gurjyot
    Lingerfelt, Brian
    Hauke, Ralph J.
    Gunuganti, Vijay
    Schnadig, Ian
    Van Veldhuizen, Peter
    Fleming, Mark
    Galamaga, Robert
    Gupta, Mukul
    Hool, Hugo
    Hutson, Thomas
    Zhang, Joshua
    McHenry, M. Brent
    Johansen, Jennifer L.
    Tykodi, Scott S.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (06) : 461 - +
  • [33] KEYNOTE-427 cohort B: First-line pembrolizumab (pembro) monotherapy for advanced non-clear cell renal cell carcinoma (NCC-RCC).
    Lee, Jae-Lyun
    Ziobro, Marek
    Gafanov, Rustem
    Matveev, Vsevolod Borisovich
    Suarez, Cristina
    Donskov, Frede
    Pouliot, Frederic
    Alekseev, Boris Yakovlevich
    Wiechno, Pawel J.
    Tomczak, Piotr
    Climent, Miguel Angel
    Shin, Sang Joon
    Silverman, Rachel Kloss
    Perini, Rodolfo F.
    Schloss, Charles
    McDermott, David F.
    Atkins, Michael B.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] Preliminary results from a phase II clinical study of first-line drugs combined with stereotactic body radiotherapy (SBRT) in the treatment of oligoprogressive renal cell carcinoma
    Zhang, Xinyue
    Liu, Ruiqi
    Liu, Yang
    Zhang, Zhiling
    Gao, Jianming
    Guo, Shengjie
    Han, Hui
    Zhou, Fangjian
    Dong, Pei
    He, Liru
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] Cabozantinib for the treatment of patients with metastatic non-clear cell renal cell carcinoma: A retrospective analysis
    Campbell, Matthew T.
    Bilen, Mehmet A.
    Shah, Amishi Y.
    Lemke, Emily
    Jonasch, E.
    Venkatesan, A. M.
    Altinmakas, E.
    Duran, C.
    Msaouel, Pavlos
    Tannir, N. M.
    EUROPEAN JOURNAL OF CANCER, 2018, 104 : 188 - 194
  • [36] Comparison of the efficacy of sunitinib and pazopanib in patients with advanced non-clear renal cell carcinoma
    Yildirim, Hasan Cagri
    Bayram, Ertugrul
    Chalabiyev, Elvin
    Majidova, Nargiz
    Avci, Tugay
    Guzel, Halil Goksel
    Kapar, Caner
    Uzun, Mehmet
    Perkin, Perihan
    Akgul, Fahri
    Yildirim, Saadet Sim
    Sali, Seda
    Yildiz, Anil
    Kazaz, Seher Nazli
    Hendem, Engin
    Arcagok, Murat
    Tufan, Gulnihal
    Yildirim, Umit
    Akgul, Omer Faruk
    Arslan, Cagatay
    Taban, Hakan
    Sahin, Eren
    Caglayan, Melek
    Esen, Ramazan
    Oksuzoglu, Berna
    Guven, Deniz Can
    Kaplan, Muhammet Ali
    Araz, Murat
    Basaran, Mert
    Cubukcu, Erdem
    Gokmen, Erhan
    Cicin, Irfan
    Algin, Efnan
    Semiz, Huseyin Salih
    Tural, Deniz
    Ozturk, Banu
    Erdogan, Atike Pinar
    Sari, Murat
    Kara, Oguz
    Erman, Mustafa
    JOURNAL OF CHEMOTHERAPY, 2024,
  • [37] Long-term treatment outcomes of patients with non-clear cell renal cell carcinoma
    Mukhomedyarova, A. A.
    Alekseev, B. Ya
    Kalpinskiy, A. S.
    ONKOUROLOGIYA, 2021, 17 (03): : 39 - 46
  • [38] Outcomes of Patients With Advanced Renal Cell Carcinoma With Non-Clear Cell Histology Treated With Systemic Therapy
    Urman, Danielle
    Deshler, Leah
    Weise, Nicole
    Shabaik, Ahmed
    Derweesh, Ithaar
    Bagrodia, Aditya
    Rose, Brent
    Herchenhorn, Daniel
    McKay, Rana R.
    CLINICAL GENITOURINARY CANCER, 2023, 21 (06) : 660 - 668.e1
  • [39] Multicenter prospective phase II study of sunitinib in non-clear cell type renal cell carcinoma
    Lee, J.
    Ahn, J.
    Lim, H.
    Lee, S.
    Kim, T.
    Lee, D.
    Cho, Y. M.
    Hong, J.
    Kim, C.
    Ahn, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [40] A phase II study of lenvatinib plus everolimus in patients with advanced non-clear cell renal cell carcinoma (nccRCC)
    Hutson, Thomas E.
    Michaelson, M. Dror
    Kuzel, Timothy M.
    Agarwal, Neeraj
    Molina, Ana M.
    Hsieh, James J.
    Vaishampayan, Ulka N.
    Xie, Sharon
    Bapat, Urmi
    Jain, Rohit K.
    Fishman, Mayer N.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
12345